Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer shareholders call on CEO to stem the tide of bad news
01:03am, Friday, 15'th Nov 2024
Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 2
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDIA® (finerenone)
Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales
02:40pm, Tuesday, 12'th Nov 2024
BAYRY's third-quarter earnings get affected due to impairment losses at the Crop Science division. Sales gain from the Pharmaceutical business's strong performance.
Bayer AG (BAYZF) Q3 2024 Earnings Call Transcript
02:14pm, Tuesday, 12'th Nov 2024
Bayer AG (OTCPK:BAYZF) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Julio Triana - President, Consumer Health
Bayer Stock: Assessing Upside Potential After Its Q3 Earnings
08:30am, Tuesday, 12'th Nov 2024
Bayer faces significant risks from litigation and poor M&As, but its current low valuation presents a potential long-term upside, especially post-2025. Despite recent challenges and a dividend cut, Ba
Bayer Stock Slumps on Outlook Cut
07:40am, Tuesday, 12'th Nov 2024
Bayer shares are falling 11% in German trading after the pharmaceuticals and crop science conglomerate reduced its full-year earnings target and warned of likely lower profit next year amid a tough ag
Bayer's stock slumps after warning on crop-sciences unit
07:08am, Tuesday, 12'th Nov 2024
Bayer's stock slumped on Tuesday as the German giant gave a profit warning on agricultural demand.
Bayer cuts FY operating earnings outlook on weak agriculture markets
01:47am, Tuesday, 12'th Nov 2024
Bayer on Tuesday lowered its full-year operating earnings guidance, citing weaker agricultural markets in Latin America.
Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint
10:17am, Wednesday, 30'th Oct 2024
BASEL, Switzerland--(BUSINESS WIRE)--Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in par
Bayer Seeks Approval for Elinzanetant for Vasomotor Symptoms in EU
10:51am, Wednesday, 16'th Oct 2024
BAYRY submits an application seeking EMA approval of elinzanetant for treating hot flashes associated with menopause or adjuvant endocrine therapy.
Bayer submits EU marketing application for menopause relief drug
03:34am, Tuesday, 15'th Oct 2024
Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.
Bayer applies for third indication of Nubeqa in EU
04:20am, Monday, 14'th Oct 2024
Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with androgen deprivation therapy.
Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU
04:00am, Monday, 14'th Oct 2024
ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion's collaborat
Bayer must pay $78 mln in latest Roundup cancer trial, jury finds
04:30pm, Thursday, 10'th Oct 2024
Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.
Bayer shares down 7% after U.S. court says it will review Monsanto case
08:22am, Wednesday, 09'th Oct 2024
Shares of German life sciences company Bayer fell more than 7% on Wednesday, after a U.S. court said it would review a case alleging that exposure products made by the company's Monsanto unit harmed i
